1. Field of the Invention
The present invention relates to methods and related devices for forming a passageway in a heart wall and delivering a stent therein to supply oxygenated blood flow to vascular structure from a chamber of the heart. For example, the methods and related devices preferably place a stent in the left ventricular heart wall in order to establish a supply of blood from the left ventricle to the coronary artery at a point distal a partial or total occlusion of the artery.
2. Background of the Related Art
A prevalent form of heart failure involves the build-up of plaque on walls of various vascular structure, such as, for example, the coronary artery. The plaque that builds up on the walls can form either a partial or total occlusion in the artery. Such an occlusion may either limit or completely block blood flow through the artery, which typically enters through the aortic valve from the left ventricle. Because the coronary artery supplies blood to the various blood vessels within the muscle forming the heart wall, limiting or blocking of the blood flow through the coronary artery can result in damage to the heart muscle, such as, for example, necrosis. Necrotic tissue can lead to reduced cardiac function by diminishing the pumping capacity of the heart. In some instances, the diminished capacity of the heart can lead to heart attack.
Various techniques have been developed to treat this type of heart condition. For example, a surgical technique, referred to as coronary artery bypass grafting (CABG), involves removing a vein or portion thereof from the patient, usually from the femoral vein, and grafting the vein so as to connect portions of the coronary artery upstream and downstream of the occlusion. Thus, the blood flow is directed around the occlusion and through the vein graft so that the oxygenated blood can be delivered to the vessels in the heart wall. CABG generally is performed as an open surgery resulting in relatively long recovery times. Patients also often experience a large amount of discomfort resulting from harvesting of the veins to be used in CABG. Furthermore, the veins that are grafted to the coronary artery have a limited useful life.
Coronary angioplasty represents another form of treatment of arteries having occlusions that can be performed as an alternative to bypass surgery. In this technique, a balloon catheter is inserted percutaneously into the coronary artery. Once the catheter has been inserted such that the balloon is adjacent the occlusion being treated, the balloon is inflated to dilate the artery in the location of the occlusion. Often this technique involves inflating and deflating the balloon repeatedly to establish the desired dilation of the artery. This technique may include placing a stent in a collinear manner in the artery at the location of the occlusion to maintain the proper dilation of the artery. Delivery of the stent can be accomplished by removing the dilation balloon catheter and then inserting a balloon carrying the stent. A multiple balloon stent delivery catheter may dilate the artery and place the stent in a single insertion of the catheter into the patient.
Another technique that has been used to bypass a partial or total occlusion of the artery includes implanting a stent, or otherwise creating a flow passage, in the myocardial wall between the left ventricle and coronary artery at a position downstream of the occlusion. In this technique, a portion of the blood pumped from the left ventricle flows directly into the coronary artery.
The advantages and purpose of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The advantages and purpose of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
The present invention pertains to methods, and related tools for performing the method, of delivering a stent or other like-device to the heart to connect the left ventricle to the coronary artery to thereby supply blood directly from the ventricle to the coronary artery. In a preferred embodiment, a method may be used to bypass a total or partial occlusion of a coronary artery. The inventive method is relatively quicker and less invasive than other techniques as a result, for example, of the manner in which the device is implanted into the heart and the elimination of the need to harvest veins from the patient to perform a CABG. Moreover, the delivery technique according to an embodiment of the present invention facilitates connecting the ventricle and coronary artery via a stent, the technique ultimately reducing the risk of damage to the coronary artery, as will be explained.
An aspect of the invention includes a method to provide direct blood flow between a heart chamber and a coronary vessel. The method includes placing a guide device through an anterior wall and a posterior wall of the coronary vessel and through a heart wall between the heart chamber and the coronary vessel, forming a passageway in the heart wall at a location defined by the guide device, and placing a stent within the passageway. The method may include insertion of a hollow needle through the anterior wall and the posterior wall of the coronary vessel and through the heart wall, prior to placing the guide device. The guide device may be, for example, a guidewire or other suitable like guide mechanism. According to an aspect of the invention, placing the guide device includes inserting the guidewire through the hollow needle until an end of the guidewire rests in the heart chamber. The hollow needle may be removed after inserting the guidewire through the hollow needle.
According to another aspect of the invention, the method may also include measuring a depth of insertion of the hollow needle. The measuring may be accomplished by viewing markings on the hollow needle that indicate the depth of insertion of the hollow needle or determining a pressure differential between the heart chamber and exterior the heart chamber.
The method according to another aspect of the present invention also includes avoiding intracardiac structures during insertion of the hollow needle, and placing the guide device at a predetermined angle relative to the posterior wall of the coronary vessel, which may include inserting a hollow needle at the predetermined angle through the anterior wall and the posterior wall of the coronary vessel and the heart wall, prior to placing the guide device.
In an aspect of a method of the present invention, the passageway is formed with a dilation device, such as a sheath or an inflation device, which may be in the form of a balloon for example. Forming the passageway may include inserting a balloon into the location defined by the guide device and inflating the balloon. A catheter may carry the balloon over the guide device. The balloon is preferably deflated after forming the passageway and removed from the passageway after deflation.
In another aspect of the invention, a stent is placed with an inflation device. The inflation device may be a balloon that carries the stent, and placing the stent includes inserting the balloon and the stent within the passageway and inflating the balloon. A catheter may carry the balloon and the stent over the guide device.
In another embodiment of the present invention, the passageway is formed and the stent is placed by a catheter carrying a first inflation device and a second inflation device. The first inflation device may be a first balloon and the second inflation device may be a second balloon. The catheter is inserted over the guide device so that the first balloon is positioned in the location defined by the guide device. The first balloon is inflated to form the passageway and deflated after forming the passageway. The catheter then is further inserted over the guide device so that the second balloon is positioned in the passageway. The second balloon may carry a stent. The second balloon is inflated to place the stent within the passageway.
According to another aspect, the invention includes a method of providing direct blood flow between a heart chamber and a coronary vessel that includes inserting an inflation device through an anterior wall and a posterior wall of the coronary vessel and into the heart wall, inflating the inflation device within the heart wall to form a passageway between the heart chamber and the coronary vessel, and placing a stent within the passageway. Inserting the inflation device may include inserting the inflation device over a guide device extending between the heart wall and exterior the heart chamber and the coronary vessel.
Yet another aspect of the invention includes a device for measuring the depth of penetration from an anterior wall of a coronary vessel to a heart chamber. The device includes a hollow needle defining a lumen and having a distal end and a proximal end. A depth indication mechanism is disposed on an external surface of the hollow needle and a handle is disposed on the proximal end of the needle. The handle includes an inner portion in flow communication with the hollow needle and a portion of the handle is transparent so that blood from the left ventricle that enters the handle from the lumen of the needle can be observed.
According to yet another aspect of the invention, a device for placing a stent in a heart wall comprises a delivery tool configured to deliver the stent to a location within the heart wall and a stop mechanism disposed on the delivery tool such that the stop mechanism is proximate at least one end of the stent during delivery of the stent. The stop mechanism may be configured to engage a surface to determine the placement location of the stent within the heart wall.
According to another aspect, the invention includes a device for placement in a passageway between a heart chamber and a coronary vessel. The device includes a hollow conduit and a plurality of extensions protruding from an end of the conduit. The plurality of extensions can include a pair of extensions at opposite sides of the conduit.
The foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description, serve to explain the principles of the invention.
a and 15b each is a myocardial passageway having the stent of
An aspect of the present invention includes a novel method of placing a stent within the heart wall between the left ventricle and the coronary artery to provide blood flow directly therebetween. The novel method generally includes the steps of establishing a position of a passageway between the left ventricle and the coronary artery, creating the passageway, and placing a stent in the passageway. Each of these general steps will be described in greater detail below.
Although the methods according to the invention will be described with reference to establishing direct blood flow between the left ventricle and left anterior descending coronary artery, connections between other heart structures and vessels to establish flow therebetween also are within the scope of the invention. In addition, the inventive methods may be used in other settings, aside from the heart, that require creating a passage or conduit and delivering a device into the created passage to establish direct flow communication between two volumes, especially between volumes that may be difficult to access.
Once implanted, conduit 12 extends from the posterior wall 14 of the coronary artery CA to the left ventricle LV. The posterior wall 14 refers to that portion of the arterial wall that interfaces with the heart wall. The anterior wall 16 of the coronary artery refers to a portion of the arterial wall that does not interface with the heart wall. In one preferred embodiment, conduit 12 lies substantially flush with the interface between posterior wall 14 of coronary artery CA and the exterior surface of heart wall HW surrounding left ventricle LV, as negative effects may result if conduit 12 protrudes into coronary artery CA or is recessed within the myocardium. For example, if conduit 12 protrudes too far into coronary artery CA, blood flow through coronary artery CA, as well as blood flow exiting conduit 12 may become disturbed, resulting in stasis. On the other hand, if conduit 12 is recessed within the myocardium such that a space remains between conduit 12 and posterior wall 14 of the CA, the space may become occluded with tissue, thereby preventing flow into CA.
The method according to an embodiment of the present invention includes forming a passage in the heart wall and implanting a conduit 12, preferably in the form of a collapsible stent, in the passage to establish direct flow communication between the left ventricular chamber and the left anterior descending coronary artery. In a preferred method of the present invention, a first step includes providing access to the location of the heart wall at which the stent 12 will be implanted. According to the invention, access to the heart wall surrounding the left ventricle LV is obtained from outside the coronary artery CA. A hollow needle 50, shown in
Insertion of the needle should avoid damaging or otherwise interfering with critical internal cardiac structures such as, for example, the papillary muscles, chordae, the mitral valve, etc. To avoid such damage, a visualization technique may be employed either prior to insertion of the needle or concurrently with the insertion of the needle. Such visualization techniques can include, for example, the use of transesophogeal, intraventricular, intracardiac, or epicardial ultrasonic probes, or a combination thereof.
In a preferred form of the invention, the stent 12 will be implanted at an angle in the heart wall. The angle of the stent 12 to the heart wall preferably is chosen according to fluid flow analyses that seek to optimize the blood flow path from the left ventricle to the coronary artery and minimize energy losses due to poor entry and exit angles, and the like. In the case of an angularly implanted stent, hollow needle 50 also will have to enter the heart wall at the appropriate angle. To properly angle hollow needle 50, a positioning tool preferably is employed. A preferred embodiment of such a positioning tool is shown in FIG. 2. Positioning tool 20 is a hollow tube preferably made of a substantially rigid material. Positioning tool 20 includes a first portion 22 connected to a second portion 24 at a hinge 26. First portion 22 has opposite ends 28, 30, and second portion 24 has an end 32 opposing end 30 and another end not shown in FIG. 2. In use, portion 22 is inserted into the coronary artery and portion 24 extends outside of the heart with end 32 open and facing towards the posterior wall of the coronary artery and the heart wall. The user bends portion 24 relative to portion 22 at hinge 26 so that portions 22 and 24 are at an appropriate angle. The user then can insert the hollow needle through portion 24 and into the heart wall at the desired angle.
After hollow needle 50 has punctured both the anterior and posterior walls of coronary artery CA, and has traversed the heart wall to enter into left ventricle LV, it may be desirable to measure the depth of penetration of the needle and thereby determine the thickness of the heart wall from the depth of needle penetration. This determination will be used later when, for example, choosing an appropriate balloon length for forming a passage between the left ventricle and the coronary artery, and choosing an appropriate length conduit to place in the passage. Therefore, on its external surface, the needle is provided with a depth indication mechanism. A preferable depth indication mechanism includes providing graduated markings representing various lengths on a proximal end of the needle. Once the needle penetrates through the ventricular wall and into the chamber, causing a reflux of blood through the needle, the depth of penetration is measured by the marking adjacent the anterior wall of the coronary artery. To then determine the thickness of the ventricular wall, the diameter of the coronary artery at the insertion site must be subtracted from the depth of needle penetration. This coronary artery diameter may be determined preoperatively by appropriate imaging techniques. Preferably, the preoperative image will show the location of the occlusion, the appropriate location for insertion of the needle, and the coronary artery diameter at that location.
An alternative depth indication mechanism includes an indicator 52 slidably disposed on needle 50. An example of such an indicator is shown in FIG. 4. Marker 52 defines an aperture through which needle 50 is inserted. The aperture preferably is sized such that marker 52 easily, yet controllably, slides along the length of the needle. That is, the aperture preferably is sized such that marker 52 frictionally engages with the needle and thus cannot slide along the needle unless a sufficient force is applied to the marker. Marker 52 abuts the anterior wall 16 of the coronary artery CA and slides along the length of the needle as the needle is inserted into the left ventricle LV. After needle 50 is removed, the depth of penetration is indicated by measuring the length from the distal end of needle 50 to marker 52. As a further alternative, graduated markings could be provided on the needle along with the marker to assist in determining the depth of penetration. Again, the actual thickness of the ventricular wall is determined by subtracting the diameter of the coronary artery (which preferably is determined using a visualization technique, such as echocardiography for example) from the depth of penetration measurement.
As a further alternative device and method for aiding the accurate determination of the depth of needle insertion, the needle may include a suitable pressure transducer at the tip of the needle. The pressure transducer would sense the pressure of the left ventricle to accurately indicate when the needle enters the left ventricle. Once such a pressure is indicated, the depth of penetration is determined by the graduated markings on the outside of the needle, as explained above.
After hollow needle 50 has been inserted through the coronary artery CA and heart wall, and into the left ventricle LV, such that a path having the desired angle and positioning relative to internal heart structures has been created, a guidewire 60 or other suitable guide device is placed within the lumen of hollow needle 50 and extended therethrough. The guidewire 60 preferably has a tip portion which is relatively flexible while the portion of the guidewire to be positioned in the myocardium preferably is relatively stiff. After the guidewire has been extended between the left ventricular chamber LV and external to the anterior wall of the coronary artery CA, the needle can be removed by sliding it off the guidewire. The placement of guidewire 60 allows a pathway to be maintained so that the myocardium and left ventricular chamber can be accessed from outside the heart.
The next step of an embodiment of the inventive method includes forming a passageway in the heart wall at the location in which stent 12 will be implanted. Preferably, the passageway will be formed using a dilation mechanism, and more preferably an inflatable dilation mechanism. The inflatable dilation mechanism can be positioned in the heart wall in a deflated configuration and then inflated to thereby dilate the heart wall, thus forming the passageway. A preferred inflatable dilation mechanism for forming such a passageway includes a balloon catheter 70, such as the one shown in FIG. 6. The balloon catheter can be fed over the guidewire with a dilation balloon 71 in a deflated condition. Thus, the catheter carrying a deflated dilation balloon advances through the anterior and posterior walls of the coronary artery and into the wall surrounding the left ventricle. The catheter may be inserted until balloon 71 resides within the heart wall. Preferably, the balloon has a length corresponding to approximately the thickness of the heart wall, and more preferably greater than or equal to the thickness of the heart wall, as measured during insertion of the hollow needle with either the measuring devices described above or through the use of utlrasound or the like. If the length of the balloon is greater than the thickness of the heart wall, the balloon may be positioned such that the excess length extends into the ventricle. The diameter of the inflated balloon is chosen so as to approximate the dimensions of the stent, for example diameter and length, that is desired in the heart wall. To facilitate positioning of the catheter, and in particular the balloon, with respect to the heart wall, a visualization technique, such as ultrasound or fluoroscopy, for example, or a mechanical mechanism, such as a mechanical stop, which may be formed by the balloon itself as will be explained shortly, may be utilized.
Once the catheter has been advanced such that dilation balloon 71 resides substantially within the heart wall, an inflation mechanism (not shown) is actuated to inflate the balloon. Balloon 71 is inflated as necessary to dilate the heart wall, causing a passageway to be formed therein, as shown in FIG. 6. The balloon preferably is made of a semi-compliant material to impart the appropriate dilation force to the heart wall. Preferably, the balloon will be inflated to a diameter corresponding to less than the maximum inflation extent of the balloon. This amount of inflation preferably will correspond to the desired dimensions, diameter and length, of the formed passageway. After dilating the heart wall and forming a passageway having desired dimensions, the balloon is deflated and removed from the passageway and the heart wall.
After removing the dilation balloon, the next step includes delivery of the stent into the as-formed passageway using a suitable delivery mechanism. In a preferred embodiment of this step, an inflatable delivery mechanism carrying the stent, such as a delivery balloon with stent 12 loaded thereon, is inserted into the passageway formed in the heart wall. Preferably, the balloon carrying the stent 12 is deflated and stent 12 is a collapsible stent that will be in a collapsed state when loaded onto the deflated delivery balloon. The stent 12 can be held in place on the delivery balloon by inflation pressure or other suitable mechanism.
As with dilation balloon 71, delivery balloon 76 (shown in
In an embodiment of the invention, the length of delivery balloon 76 exceeds the length of stent 12 while collapsed. Stent 12 may be loaded onto the delivery balloon such that the deflated delivery balloon extends beyond each end of stent 12, and preferably at least from the proximal end of stent 12. As a result of extending beyond both ends of the stent, the balloon can expand during deployment beyond the ends of stent 12 and attain a dumbbell-like shape. In this manner, as illustrated for example in
Other embodiments of the inventive method include using a sheath as a dilation mechanism to form the passageway in the heart wall and to deliver the catheter carrying the stent to the heart wall. In embodiments using a sheath, after positioning the guide device in the desired location in the heart wall, a sheath may be advanced over the guidewire and inserted through the coronary artery and heart wall. The sheath will dilate the heart wall to form the passageway. Graduated markings may be placed on the outside of the sheath to determine the depth of penetration in the heart wall. A stent to be delivered may be preloaded on a balloon catheter and inserted over the guidewire and through the sheath to the appropriate position in the heart wall.
In conjunction with this sheath delivery technique described above, various mechanisms, as shown for example in
After appropriate positioning of stent 12, a locking mechanism (not shown) on sheath 200 may be used to fix the position of catheter 132. Once stent 12 has been placed within the heart wall, sheath 200 and catheter 132 may be removed from the heart. To remove sheath 200, basket 133 first must be retracted or compressed.
Regardless of the delivery technique employed, stent 12 preferably will be selected such that, upon full expansion, the conduit will have dimensions that cause the passageway in the heart wall to remain open, thereby creating a permanent passageway between the left ventricle and the coronary artery. Moreover, stent 12 preferably will have a length that approximately equals or is greater than the thickness of the heart wall. More preferably, the length of stent 12 is large enough to allow a small end portion of stent 12 to reside in the left ventricular chamber in order to prevent invagination of the tissue around the opening of the stent. Even more preferably, the length of the stent may be chosen such that it covers the systolic depth of the heart wall measured from the posterior wall of the coronary artery to the inner surface of the left ventricular wall. This systolic depth may be determined using visualization techniques, such as echocardiography, for example. In any case, the length of the stent 12 to be used may be determined from the measurements of the heart wall determined previously, for example using the hollow needle, in combination with the determination of the coronary artery diameter using appropriate visualization techniques.
In addition, the stent preferably will be made of or coated internally with a material that prevents heart wall tissue, blood, and debris from prolapsing into the stent. Such a material may include a woven or a non-woven polymer that is compatible with blood and has low thrombogenicity, or other coatings to improve resistance to thrombus formation or tissue overgrowth. Coatings that enhance endothelial cell formation also are desired. Moreover, the stent may include a drug delivery coating. Other materials exhibiting these characteristics while also allowing deployment by the inventive method also are within the scope of the invention.
A further preferable feature of the stent to be implanted in the heart wall includes a flow controller disposed within the stent. Such a flow controller preferably would bias flow in the net forward direction, i.e., in the direction flowing from the ventricle to the coronary artery. Flow control mechanisms of this type include autologous vein sections, xenograft vein or valve sections, tilting disks, ball-in-cage valves, tapered shunt configurations, lobed duckbill flaps, mechanical poppets, pressure or electrically activated valves, and other suitable like mechanisms. Examples of various flow control mechanisms used with stents to create a net forward flow from the left ventricle to the coronary artery can be found in commonly-owned U.S. patent application Ser. No. 09/368,393, filed Aug. 4, 1999, and entitled “Valve Designs for Left Ventricular Conduits.” The entire disclosure of that application is incorporated by reference herein.
In another embodiment of a flow controller, a stent may be used to create a natural valving mechanism to reduce the potential occurrence of backflow of blood from the coronary artery to the left ventricle during portions of the cardiac cycle, particularly diastole. This will be described in connection with
This placement of the stent, along with the struts 100, causes natural valving to occur, as described with reference to
Once stent 12 has been expanded and positioned in the passageway in the heart wall, the delivery balloon is deflated. The catheter carrying the delivery balloon can then be removed from the patient by sliding it over the guidewire. The guidewire also can be removed from the patient and the puncture site in the artery can be closed via conventional suturing methods and/or surgical sealants, or other suitable closure techniques and mechanisms. In certain embodiments, a closing device similar to those used and known to close a patent foramen ovale may be used. Also, the inner part of the closing device which covers the inner surface of the coronary artery may be constructed without any Dacron or covering material as long as the fixation of the closing device is maintained by suitable fixation members. An outer portion of the closing device, made for example of a biocompatible covering material like Dacron, may then be connected to the inner portion of the closing device to close the hole.
Alternatively, it may be possible to close the hole in the anterior wall of the artery by retracting the wall of the artery without any closing device. Such a technique would be similar to using a suture, but would not require assistance by the surgeon. For example, as the hole in the artery is formed by introducing a sheath over a wire, the tissue surrounding the hole is compressed around the sheath. After removing the sheath, this tissue will tend to cause a portion of the artery wall to retract to close the hole. To assist in this process, a small outer ring may be fixed to the outside surface of the artery. This outer ring may be formed of a suitable closure material, such as a suture or glue. The ring may be applied prior to removing the sheath, essentially using the outer surface of the sheath as an applicator. Once the ring is fixed to the outer surface of the coronary artery, the sheath may be removed. The ring may then retract the tissue surrounding the hole to close the hole in the coronary artery.
As discussed above, the steps of dilating the heart wall using a balloon catheter to form the passageway and implanting the conduit can be performed by using separate catheters for each step, a first catheter carrying the dilation balloon and a second catheter carrying the delivery balloon and stent. As an alternative, a single catheter carrying both a delivery balloon and a dilation balloon and stent in a collinear manner may be used. If two separate catheters are employed, one carrying the dilation balloon and one carrying the delivery balloon, a catheter exchange technique is employed. That is, after the catheter carrying the dilation balloon has been employed to form the passageway in the heart wall, the dilation balloon will be deflated and the catheter will be slid along the guidewire and removed from the patient. Then, the catheter carrying the delivery balloon with the collapsed stent loaded thereon is inserted over the guidewire and into the correct position with respect to the heart wall, and the conduit is implanted as described above.
If a single catheter carrying both the dilation and the delivery balloons is employed, the method is performed in the following manner.
In one aspect of the invention, the method includes using a multiple balloon stent delivery catheter of the type shown in
Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. The specification and examples are exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
This application claims the benefits of U.S. Provisional Patent Application Ser. No. 60/201,732, filed May 4, 2000.
Number | Name | Date | Kind |
---|---|---|---|
3971363 | Fletcher et al. | Jul 1976 | A |
4503568 | Madras | Mar 1985 | A |
4733665 | Palmaz | Mar 1988 | A |
4769029 | Patel | Sep 1988 | A |
4953553 | Tremulis | Sep 1990 | A |
4995857 | Arnold | Feb 1991 | A |
5035702 | Taheri | Jul 1991 | A |
5135467 | Citron | Aug 1992 | A |
5190058 | Jones et al. | Mar 1993 | A |
5193546 | Shaknovich | Mar 1993 | A |
5226889 | Sheiban | Jul 1993 | A |
5258008 | Wilk | Nov 1993 | A |
5287861 | Wilk | Feb 1994 | A |
5292309 | Van Tassel et al. | Mar 1994 | A |
5330486 | Wilk | Jul 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5385541 | Kirsch et al. | Jan 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5409019 | Wilk | Apr 1995 | A |
5423744 | Gencheff et al. | Jun 1995 | A |
5423851 | Samuels | Jun 1995 | A |
5429144 | Wilk | Jul 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5456694 | Marin et al. | Oct 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5456714 | Owen | Oct 1995 | A |
5470320 | Tiefenbrun et al. | Nov 1995 | A |
5527337 | Stack et al. | Jun 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5578075 | Dayton | Nov 1996 | A |
5593434 | Williams | Jan 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5611778 | Brinon | Mar 1997 | A |
5618299 | Khosravi et al. | Apr 1997 | A |
5643278 | Wijay | Jul 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5662124 | Wilk | Sep 1997 | A |
5676670 | Kim | Oct 1997 | A |
5733267 | Del Toro | Mar 1998 | A |
5755682 | Knudson et al. | May 1998 | A |
5758663 | Wilk et al. | Jun 1998 | A |
5797920 | Kim | Aug 1998 | A |
5797933 | Snow et al. | Aug 1998 | A |
5807384 | Mueller | Sep 1998 | A |
5810836 | Hussein et al. | Sep 1998 | A |
5810871 | Tuckey et al. | Sep 1998 | A |
5824038 | Wall | Oct 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5843163 | Wall | Dec 1998 | A |
5851232 | Lois | Dec 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5865723 | Love | Feb 1999 | A |
5876373 | Giba et al. | Mar 1999 | A |
5876419 | Carpenter et al. | Mar 1999 | A |
5878751 | Hussein et al. | Mar 1999 | A |
5885259 | Berg | Mar 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5908028 | Wilk | Jun 1999 | A |
5908029 | Knudson et al. | Jun 1999 | A |
5922022 | Nash et al. | Jul 1999 | A |
5925012 | Murphy-Chutorian et al. | Jul 1999 | A |
5931848 | Saadat | Aug 1999 | A |
5935119 | Guy et al. | Aug 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5935162 | Dang | Aug 1999 | A |
5938632 | Ellis | Aug 1999 | A |
5944019 | Knudson et al. | Aug 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5968093 | Kranz | Oct 1999 | A |
5971993 | Hussein et al. | Oct 1999 | A |
5976153 | Fischell et al. | Nov 1999 | A |
5976155 | Foreman et al. | Nov 1999 | A |
5976159 | Bolduc et al. | Nov 1999 | A |
5976169 | Imran | Nov 1999 | A |
5976181 | Whelan et al. | Nov 1999 | A |
5976182 | Cox | Nov 1999 | A |
5976192 | McIntyre et al. | Nov 1999 | A |
5976650 | Campbell et al. | Nov 1999 | A |
5979455 | Maginot | Nov 1999 | A |
5980530 | Willard et al. | Nov 1999 | A |
5980533 | Holman | Nov 1999 | A |
5980548 | Evans et al. | Nov 1999 | A |
5980551 | Summers et al. | Nov 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
5980553 | Gray et al. | Nov 1999 | A |
5980566 | Alt et al. | Nov 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
5984956 | Tweden et al. | Nov 1999 | A |
5984963 | Ryan et al. | Nov 1999 | A |
5984965 | Knapp et al. | Nov 1999 | A |
5989207 | Hughes | Nov 1999 | A |
5989263 | Shmulewitz | Nov 1999 | A |
5989287 | Yang et al. | Nov 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
5993482 | Chuter | Nov 1999 | A |
5997525 | March et al. | Dec 1999 | A |
5997563 | Kretizers | Dec 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
5999678 | Murphy-Chutorian et al. | Dec 1999 | A |
6001123 | Lau | Dec 1999 | A |
6004261 | Sinofsky et al. | Dec 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6004348 | Banas et al. | Dec 1999 | A |
6007543 | Ellis et al. | Dec 1999 | A |
6007575 | Samuels | Dec 1999 | A |
6007576 | McClellan | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6010530 | Goicoechea | Jan 2000 | A |
6017365 | Van Oepen | Jan 2000 | A |
6026814 | LaFontaine et al. | Feb 2000 | A |
6029672 | Vanney et al. | Feb 2000 | A |
6035856 | LaFontaine et al. | Mar 2000 | A |
6036677 | Javier, Jr. et al. | Mar 2000 | A |
6036697 | DiCaprio | Mar 2000 | A |
6039721 | Johnson et al. | Mar 2000 | A |
6042581 | Ryan et al. | Mar 2000 | A |
6045565 | Ellis et al. | Apr 2000 | A |
6053911 | Ryan et al. | Apr 2000 | A |
6053924 | Hussein | Apr 2000 | A |
6053942 | Eno et al. | Apr 2000 | A |
6056743 | Ellis et al. | May 2000 | A |
6067988 | Mueller | May 2000 | A |
6068638 | Makower | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6076529 | Vanney et al. | Jun 2000 | A |
6080163 | Hussein et al. | Jun 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6092526 | LaFontaine et al. | Jul 2000 | A |
6093166 | Knudson et al. | Jul 2000 | A |
6093177 | Javier, Jr. et al. | Jul 2000 | A |
6093185 | Ellis et al. | Jul 2000 | A |
6095997 | French et al. | Aug 2000 | A |
6102941 | Tweden et al. | Aug 2000 | A |
6106538 | Shiber | Aug 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6113630 | Vanney et al. | Sep 2000 | A |
6113823 | Eno | Sep 2000 | A |
6117165 | Becker | Sep 2000 | A |
6120520 | Saadat et al. | Sep 2000 | A |
6123682 | Knudson et al. | Sep 2000 | A |
6126649 | Van Tassel et al. | Oct 2000 | A |
6126654 | Giba et al. | Oct 2000 | A |
6132451 | Payne et al. | Oct 2000 | A |
6139541 | Vanney et al. | Oct 2000 | A |
6152141 | Stevens et al. | Nov 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6156031 | Aita et al. | Dec 2000 | A |
6157852 | Selmon et al. | Dec 2000 | A |
6159225 | Makower | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6165185 | Shennib et al. | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6171251 | Mueller et al. | Jan 2001 | B1 |
6171303 | Ben-Haim et al. | Jan 2001 | B1 |
6182668 | Tweden et al. | Feb 2001 | B1 |
6186972 | Nelson et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6193726 | Vanney | Feb 2001 | B1 |
D438618 | Solem | Mar 2001 | S |
6196230 | Hall et al. | Mar 2001 | B1 |
6197050 | Eno et al. | Mar 2001 | B1 |
6197324 | Crittenden | Mar 2001 | B1 |
6200310 | Ben-Haim et al. | Mar 2001 | B1 |
6200311 | Danek et al. | Mar 2001 | B1 |
6203556 | Evans et al. | Mar 2001 | B1 |
6213126 | LaFontaine et al. | Apr 2001 | B1 |
6214041 | Tweden et al. | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217549 | Selmon et al. | Apr 2001 | B1 |
6217575 | DeVore et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6223752 | Vanney et al. | May 2001 | B1 |
6224584 | March et al. | May 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6237607 | Vanney et al. | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6241667 | Vetter et al. | Jun 2001 | B1 |
6248112 | Gambale et al. | Jun 2001 | B1 |
6250305 | Tweden | Jun 2001 | B1 |
6251079 | Gambale et al. | Jun 2001 | B1 |
6251116 | Shennib et al. | Jun 2001 | B1 |
6251418 | Ahern et al. | Jun 2001 | B1 |
6253768 | Wilk | Jul 2001 | B1 |
6253769 | LaFontaine et al. | Jul 2001 | B1 |
6254564 | Wilk et al. | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6258119 | Hussein et al. | Jul 2001 | B1 |
6261304 | Hall et al. | Jul 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6285903 | Rosenthal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6290709 | Ellis et al. | Sep 2001 | B1 |
6290719 | Garberoglio | Sep 2001 | B1 |
6290728 | Phelps et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6302892 | Wilk | Oct 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6330884 | Kim | Dec 2001 | B1 |
6331178 | Loeb et al. | Dec 2001 | B1 |
6344027 | Goll | Feb 2002 | B1 |
6350248 | Knudson et al. | Feb 2002 | B1 |
6352543 | Cole | Mar 2002 | B1 |
6361519 | Knudson et al. | Mar 2002 | B1 |
6363938 | Saadat et al. | Apr 2002 | B2 |
6363939 | Wilk | Apr 2002 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6379319 | Garibotto et al. | Apr 2002 | B1 |
6387119 | Wolf et al. | May 2002 | B2 |
6390098 | LaFontaine et al. | May 2002 | B1 |
6395208 | Herweck et al. | May 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6406488 | Tweden et al. | Jun 2002 | B1 |
6406491 | Vanney | Jun 2002 | B1 |
6409697 | Eno et al. | Jun 2002 | B2 |
6409751 | Hall et al. | Jun 2002 | B1 |
6416490 | Ellis et al. | Jul 2002 | B1 |
6423089 | Gingras et al. | Jul 2002 | B1 |
6432119 | Saadat | Aug 2002 | B1 |
6432126 | Gambale et al. | Aug 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6432132 | Cottone et al. | Aug 2002 | B1 |
6443158 | LaFontaine et al. | Sep 2002 | B1 |
6447522 | Gambale et al. | Sep 2002 | B2 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6454760 | Vanney | Sep 2002 | B2 |
6454794 | Knudson et al. | Sep 2002 | B1 |
6458092 | Gambale et al. | Oct 2002 | B1 |
6458140 | Akin et al. | Oct 2002 | B2 |
6458323 | Boekstegers | Oct 2002 | B1 |
6464709 | Shennib et al. | Oct 2002 | B1 |
6475226 | Belef et al. | Nov 2002 | B1 |
6475244 | Herweck et al. | Nov 2002 | B2 |
6482220 | Mueller | Nov 2002 | B1 |
6491689 | Ellis et al. | Dec 2002 | B1 |
6491707 | Makower et al. | Dec 2002 | B2 |
6506408 | Palasis | Jan 2003 | B1 |
6508783 | DeVore | Jan 2003 | B2 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6514271 | Evans et al. | Feb 2003 | B2 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6524323 | Nash et al. | Feb 2003 | B1 |
6524324 | Mueller et al. | Feb 2003 | B1 |
6528444 | Kondoh et al. | Mar 2003 | B1 |
6533779 | Kinsella et al. | Mar 2003 | B2 |
6544220 | Shuman et al. | Apr 2003 | B2 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6559132 | Holmer | May 2003 | B1 |
6561998 | Roth et al. | May 2003 | B1 |
6565528 | Mueller | May 2003 | B1 |
6565594 | Herweck et al. | May 2003 | B1 |
6569145 | Shmulewitz et al. | May 2003 | B1 |
6569147 | Evans et al. | May 2003 | B1 |
6573311 | Martakos et al. | Jun 2003 | B1 |
6582463 | Mowry et al. | Jun 2003 | B1 |
6587718 | Talpade | Jul 2003 | B2 |
6605053 | Kamm et al. | Aug 2003 | B1 |
6610100 | Phelps et al. | Aug 2003 | B2 |
6613026 | Palasis et al. | Sep 2003 | B1 |
6616626 | Crank et al. | Sep 2003 | B2 |
6632470 | Morra et al. | Oct 2003 | B2 |
6641610 | Briefs et al. | Nov 2003 | B2 |
6651670 | Rapacki et al. | Nov 2003 | B2 |
6669691 | Taimisto | Dec 2003 | B1 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6685716 | Flaherty et al. | Feb 2004 | B1 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20010004683 | Gambale et al. | Jun 2001 | A1 |
20010004690 | Gambale et al. | Jun 2001 | A1 |
20010004699 | Gittings et al. | Jun 2001 | A1 |
20010008969 | Evans et al. | Jul 2001 | A1 |
20010012924 | Milo et al. | Aug 2001 | A1 |
20010012948 | Vanney | Aug 2001 | A1 |
20010014813 | Saadat et al. | Aug 2001 | A1 |
20010016700 | Eno et al. | Aug 2001 | A1 |
20010018596 | Selmon et al. | Aug 2001 | A1 |
20010020172 | Selmon et al. | Sep 2001 | A1 |
20010025643 | Foley | Oct 2001 | A1 |
20010027287 | Shmulewitz et al. | Oct 2001 | A1 |
20010029385 | Shennib et al. | Oct 2001 | A1 |
20010034547 | Hall et al. | Oct 2001 | A1 |
20010037117 | Gambale et al. | Nov 2001 | A1 |
20010037149 | Wilk | Nov 2001 | A1 |
20010039426 | Makower et al. | Nov 2001 | A1 |
20010039445 | Hall et al. | Nov 2001 | A1 |
20010041902 | Lepulu et al. | Nov 2001 | A1 |
20010044631 | Akin et al. | Nov 2001 | A1 |
20010047165 | Makower et al. | Nov 2001 | A1 |
20010047197 | Foley | Nov 2001 | A1 |
20010049523 | DeVore et al. | Dec 2001 | A1 |
20010053932 | Phelps et al. | Dec 2001 | A1 |
20020002349 | Flaherty et al. | Jan 2002 | A1 |
20020004662 | Wilk | Jan 2002 | A1 |
20020004663 | Gittings et al. | Jan 2002 | A1 |
20020007138 | Wilk et al. | Jan 2002 | A1 |
20020029079 | Kim et al. | Mar 2002 | A1 |
20020032476 | Gambale et al. | Mar 2002 | A1 |
20020032478 | Boekstegers et al. | Mar 2002 | A1 |
20020033180 | Solem | Mar 2002 | A1 |
20020049486 | Knudson et al. | Apr 2002 | A1 |
20020049495 | Kutryk et al. | Apr 2002 | A1 |
20020058897 | Renati | May 2002 | A1 |
20020062146 | Makower et al. | May 2002 | A1 |
20020065478 | Knudson et al. | May 2002 | A1 |
20020072699 | Knudson et al. | Jun 2002 | A1 |
20020072758 | Reo et al. | Jun 2002 | A1 |
20020077566 | Laroya et al. | Jun 2002 | A1 |
20020077654 | Javier, Jr. et al. | Jun 2002 | A1 |
20020082546 | Crank et al. | Jun 2002 | A1 |
20020092535 | Wilk | Jul 2002 | A1 |
20020092536 | LaFontaine et al. | Jul 2002 | A1 |
20020095110 | Vanney et al. | Jul 2002 | A1 |
20020095111 | Tweden et al. | Jul 2002 | A1 |
20020099392 | Mowry et al. | Jul 2002 | A1 |
20020099404 | Mowry | Jul 2002 | A1 |
20020100484 | Wolf et al. | Aug 2002 | A1 |
20020103459 | Sparks et al. | Aug 2002 | A1 |
20020103495 | Cole | Aug 2002 | A1 |
20020103534 | Vanney et al. | Aug 2002 | A1 |
20020111644 | Shuman et al. | Aug 2002 | A1 |
20020111672 | Kim et al. | Aug 2002 | A1 |
20020123698 | Garibotto et al. | Sep 2002 | A1 |
20020123786 | Gittings et al. | Sep 2002 | A1 |
20020138087 | Shennib et al. | Sep 2002 | A1 |
20020143285 | Eno et al. | Oct 2002 | A1 |
20020143289 | Ellis et al. | Oct 2002 | A1 |
20020143347 | Cole et al. | Oct 2002 | A1 |
20020144696 | Sharkawy et al. | Oct 2002 | A1 |
20020161383 | Akin et al. | Oct 2002 | A1 |
20020161424 | Rapacki et al. | Oct 2002 | A1 |
20020165479 | Wilk | Nov 2002 | A1 |
20020165606 | Wolf et al. | Nov 2002 | A1 |
20020179098 | Makower et al. | Dec 2002 | A1 |
20020183716 | Herweck et al. | Dec 2002 | A1 |
20020193782 | Ellis et al. | Dec 2002 | A1 |
20030015816 | Rapacki et al. | Jan 2003 | A1 |
20030018379 | Knudson et al. | Jan 2003 | A1 |
20030044315 | Boekstegers | Mar 2003 | A1 |
20030045828 | Wilk | Mar 2003 | A1 |
20030055371 | Wolf et al. | Mar 2003 | A1 |
20030062650 | Martakos et al. | Apr 2003 | A1 |
20030073973 | Evans et al. | Apr 2003 | A1 |
20030078561 | Gambale et al. | Apr 2003 | A1 |
20030078562 | Makower et al. | Apr 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030105514 | Phelps et al. | Jun 2003 | A1 |
20030120195 | Milo et al. | Jun 2003 | A1 |
20030120259 | Mickley | Jun 2003 | A1 |
20030125798 | Martin | Jul 2003 | A1 |
20030163198 | Morra et al. | Aug 2003 | A1 |
20030181938 | Roth et al. | Sep 2003 | A1 |
20030195458 | Phelps et al. | Oct 2003 | A1 |
20030204160 | Kamm et al. | Oct 2003 | A1 |
20030212413 | Wilk | Nov 2003 | A1 |
20030216679 | Wolf et al. | Nov 2003 | A1 |
20030236542 | Makower | Dec 2003 | A1 |
20040006298 | Wilk | Jan 2004 | A1 |
20040006301 | Sell et al. | Jan 2004 | A1 |
20040015225 | Kim et al. | Jan 2004 | A1 |
Number | Date | Country |
---|---|---|
0 732 088 | Sep 1996 | EP |
0 792 624 | Sep 1997 | EP |
0 797 957 | Oct 1997 | EP |
0 797 958 | Oct 1997 | EP |
0 799 604 | Oct 1997 | EP |
0 801 928 | Oct 1997 | EP |
0 824 903 | Feb 1998 | EP |
0 829 239 | Mar 1998 | EP |
0 836 834 | Apr 1998 | EP |
0 853 921 | Jul 1998 | EP |
0 858 779 | Aug 1998 | EP |
0 876 796 | Nov 1998 | EP |
0 876 803 | Nov 1998 | EP |
0 815 798 | Jan 1999 | EP |
0 888 750 | Jan 1999 | EP |
0 895 752 | Feb 1999 | EP |
0 903 123 | Mar 1999 | EP |
0 904 745 | Mar 1999 | EP |
0 934 728 | Aug 1999 | EP |
0 955 017 | Nov 1999 | EP |
0 955 019 | Nov 1999 | EP |
0 962 194 | Dec 1999 | EP |
1 020 166 | Jul 2000 | EP |
1 027 870 | Aug 2000 | EP |
1 027 878 | Aug 2000 | EP |
1 088 564 | Apr 2001 | EP |
1 097 676 | May 2001 | EP |
1 166 721 | Jan 2002 | EP |
0 959 815 | Dec 2002 | EP |
1 112 097 | Jun 2003 | EP |
2316322 | Oct 1998 | GB |
WO 9416629 | Aug 1994 | WO |
94169629 | Aug 1994 | WO |
WO 9635469 | Nov 1996 | WO |
WO 9639962 | Dec 1996 | WO |
WO 9639964 | Dec 1996 | WO |
WO 9639965 | Dec 1996 | WO |
9713463 | Apr 1997 | WO |
9713471 | Apr 1997 | WO |
WO 9718768 | May 1997 | WO |
9727893 | Aug 1997 | WO |
9727897 | Aug 1997 | WO |
9727898 | Aug 1997 | WO |
WO 9727898 | Aug 1997 | WO |
9732551 | Sep 1997 | WO |
WO 9741916 | Nov 1997 | WO |
9741916 | Nov 1997 | WO |
WO 9743961 | Nov 1997 | WO |
WO 9802099 | Jan 1998 | WO |
WO 9803118 | Jan 1998 | WO |
9806356 | Feb 1998 | WO |
9808456 | Mar 1998 | WO |
9810714 | Mar 1998 | WO |
9816161 | Apr 1998 | WO |
WO 9817185 | Apr 1998 | WO |
WO 9819607 | May 1998 | WO |
WO 9824373 | Jun 1998 | WO |
WO 9825533 | Jun 1998 | WO |
WO 9838916 | Sep 1998 | WO |
WO 9838925 | Sep 1998 | WO |
WO 9838939 | Sep 1998 | WO |
WO 9838941 | Sep 1998 | WO |
WO 9839038 | Sep 1998 | WO |
WO 9844869 | Oct 1998 | WO |
9846115 | Oct 1998 | WO |
9846119 | Oct 1998 | WO |
WO 9849964 | Nov 1998 | WO |
WO 9853759 | Dec 1998 | WO |
WO 9855027 | Dec 1998 | WO |
WO 9857590 | Dec 1998 | WO |
WO 9857591 | Dec 1998 | WO |
WO 9857592 | Dec 1998 | WO |
9808624 | Feb 1999 | WO |
WO 9907296 | Feb 1999 | WO |
WO 9915220 | Apr 1999 | WO |
WO 9917671 | Apr 1999 | WO |
9917683 | Apr 1999 | WO |
9921490 | May 1999 | WO |
WO 9921510 | May 1999 | WO |
WO 9922655 | May 1999 | WO |
WO 9922658 | May 1999 | WO |
9925273 | May 1999 | WO |
WO 9927985 | Jun 1999 | WO |
WO 9932051 | Jul 1999 | WO |
WO 9935977 | Jul 1999 | WO |
WO 9935979 | Jul 1999 | WO |
WO 9935980 | Jul 1999 | WO |
9936000 | Jul 1999 | WO |
9936001 | Jul 1999 | WO |
WO 9937218 | Jul 1999 | WO |
9938459 | Aug 1999 | WO |
WO 9940853 | Aug 1999 | WO |
9940868 | Aug 1999 | WO |
WO 9940963 | Aug 1999 | WO |
WO 9944524 | Sep 1999 | WO |
WO 9947071 | Sep 1999 | WO |
WO 9947078 | Sep 1999 | WO |
WO 9948427 | Sep 1999 | WO |
9948545 | Sep 1999 | WO |
WO 9948549 | Sep 1999 | WO |
9949790 | Oct 1999 | WO |
9949793 | Oct 1999 | WO |
9949910 | Oct 1999 | WO |
9951162 | Oct 1999 | WO |
9952481 | Oct 1999 | WO |
9953863 | Oct 1999 | WO |
9955406 | Nov 1999 | WO |
9662430 | Dec 1999 | WO |
9960941 | Dec 1999 | WO |
0009195 | Feb 2000 | WO |
WO 0010623 | Mar 2000 | WO |
0012029 | Mar 2000 | WO |
WO 0013722 | Mar 2000 | WO |
0015146 | Mar 2000 | WO |
0015147 | Mar 2000 | WO |
0015148 | Mar 2000 | WO |
0015149 | Mar 2000 | WO |
0015275 | Mar 2000 | WO |
0018302 | Apr 2000 | WO |
WO 0018323 | Apr 2000 | WO |
WO 0018325 | Apr 2000 | WO |
WO 0018326 | Apr 2000 | WO |
WO 0018331 | Apr 2000 | WO |
WO 0018462 | Apr 2000 | WO |
0021436 | Apr 2000 | WO |
0021461 | Apr 2000 | WO |
0021463 | Apr 2000 | WO |
0024449 | May 2000 | WO |
0033725 | Jun 2000 | WO |
WO 0035376 | Jun 2000 | WO |
WO 0036997 | Jun 2000 | WO |
0041632 | Jul 2000 | WO |
0041633 | Jul 2000 | WO |
WO 0043051 | Jul 2000 | WO |
0045711 | Aug 2000 | WO |
WO 0045886 | Aug 2000 | WO |
WO 0049952 | Aug 2000 | WO |
WO 0049954 | Aug 2000 | WO |
WO 0049956 | Aug 2000 | WO |
WO 0054660 | Sep 2000 | WO |
WO 0054661 | Sep 2000 | WO |
WO 0056224 | Sep 2000 | WO |
WO 0056225 | Sep 2000 | WO |
0056387 | Sep 2000 | WO |
0066007 | Nov 2000 | WO |
0066009 | Nov 2000 | WO |
0066035 | Nov 2000 | WO |
WO 0069345 | Nov 2000 | WO |
WO 0069504 | Nov 2000 | WO |
0071195 | Nov 2000 | WO |
WO 0108566 | Feb 2001 | WO |
WO 0108602 | Feb 2001 | WO |
WO 0108602 | Feb 2001 | WO |
0110340 | Feb 2001 | WO |
0110341 | Feb 2001 | WO |
0110347 | Feb 2001 | WO |
0110348 | Feb 2001 | WO |
0110349 | Feb 2001 | WO |
WO 0110350 | Feb 2001 | WO |
0117440 | Mar 2001 | WO |
0117456 | Mar 2001 | WO |
WO 0123016 | Apr 2001 | WO |
WO 0126562 | Apr 2001 | WO |
WO 0141657 | Jun 2001 | WO |
0149187 | Jul 2001 | WO |
WO 0154625 | Aug 2001 | WO |
0160427 | Aug 2001 | WO |
WO 0168158 | Sep 2001 | WO |
WO 0170133 | Sep 2001 | WO |
WO 0172239 | Oct 2001 | WO |
0178801 | Oct 2001 | WO |
0182803 | Nov 2001 | WO |
0182837 | Nov 2001 | WO |
WO 0202163 | Jan 2002 | WO |
0211647 | Feb 2002 | WO |
WO 0211807 | Feb 2002 | WO |
WO 0213698 | Feb 2002 | WO |
WO 0213699 | Feb 2002 | WO |
WO 0213703 | Feb 2002 | WO |
WO 0213704 | Feb 2002 | WO |
WO 0224108 | Mar 2002 | WO |
WO 0224247 | Mar 2002 | WO |
WO 0224248 | Mar 2002 | WO |
WO 0226310 | Apr 2002 | WO |
WO 0226462 | Apr 2002 | WO |
WO 0230325 | Apr 2002 | WO |
WO 0230326 | Apr 2002 | WO |
WO 0230330 | Apr 2002 | WO |
WO 0232330 | Apr 2002 | WO |
WO 0234323 | May 2002 | WO |
WO 0245598 | Jun 2002 | WO |
WO 0249695 | Jun 2002 | WO |
WO 02056937 | Jul 2002 | WO |
WO 02058567 | Aug 2002 | WO |
WO 02058591 | Aug 2002 | WO |
WO 02060509 | Aug 2002 | WO |
WO 02062265 | Aug 2002 | WO |
WO 02064020 | Aug 2002 | WO |
WO 02091958 | Nov 2002 | WO |
WO 03028522 | Apr 2003 | WO |
WO 2004000170 | Dec 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20020045928 A1 | Apr 2002 | US |
Number | Date | Country | |
---|---|---|---|
60201732 | May 2000 | US |